Glenn Croston

3.2k total citations
44 papers, 2.5k citations indexed

About

Glenn Croston is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Glenn Croston has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Genetics and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Glenn Croston's work include Estrogen and related hormone effects (13 papers), Retinoids in leukemia and cellular processes (8 papers) and Neuroendocrine regulation and behavior (7 papers). Glenn Croston is often cited by papers focused on Estrogen and related hormone effects (13 papers), Retinoids in leukemia and cellular processes (8 papers) and Neuroendocrine regulation and behavior (7 papers). Glenn Croston collaborates with scholars based in United States, Denmark and Switzerland. Glenn Croston's co-authors include James T. Kadonaga, James R. Paterniti, Lily Jow, Ranjan Mukherjee, L Kerrigan, Daniel R. Marshak, Zhaodan Cao, David V. Goeddel, Alex M. Nadzan and Richard A. Heyman and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Glenn Croston

44 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn Croston United States 23 1.7k 412 272 263 253 44 2.5k
Pengxiang Huang United States 13 1.8k 1.0× 773 1.9× 594 2.2× 340 1.3× 339 1.3× 25 3.1k
Yi‐Chao Lee Taiwan 32 1.4k 0.8× 217 0.5× 215 0.8× 169 0.6× 409 1.6× 90 2.8k
Kelly Suino-Powell United States 25 1.9k 1.1× 463 1.1× 134 0.5× 456 1.7× 269 1.1× 33 3.5k
Yiming Jiang China 31 1.7k 1.0× 417 1.0× 128 0.5× 205 0.8× 470 1.9× 97 3.3k
Chakkodabylu S. Ramesha United States 11 1.2k 0.7× 230 0.6× 294 1.1× 340 1.3× 242 1.0× 13 2.2k
Kentaro Maemura Japan 22 947 0.5× 270 0.7× 546 2.0× 243 0.9× 366 1.4× 52 2.3k
László Hackler Hungary 29 1.3k 0.8× 169 0.4× 154 0.6× 267 1.0× 146 0.6× 78 2.4k
Ernesto J. Podestá Argentina 31 1.7k 1.0× 465 1.1× 176 0.6× 304 1.2× 175 0.7× 104 2.9k
Boqin Qiang China 34 2.3k 1.3× 439 1.1× 213 0.8× 246 0.9× 363 1.4× 123 3.5k
Georges Guellaën France 29 1.4k 0.8× 574 1.4× 179 0.7× 284 1.1× 364 1.4× 79 2.6k

Countries citing papers authored by Glenn Croston

Since Specialization
Citations

This map shows the geographic impact of Glenn Croston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Croston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Croston more than expected).

Fields of papers citing papers by Glenn Croston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Croston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Croston. The network helps show where Glenn Croston may publish in the future.

Co-authorship network of co-authors of Glenn Croston

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Croston. A scholar is included among the top collaborators of Glenn Croston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Croston. Glenn Croston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, W., Irene Cortés‐Puch, Cindy B. McReynolds, et al.. (2024). Randomized, double‐blind, phase 1a single‐ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers. Clinical and Translational Science. 17(9). e70033–e70033. 7 indexed citations
2.
Brossa, Alessia, Stefano Canosa, Stefania Tritta, et al.. (2022). Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells. International Journal of Molecular Sciences. 23(3). 1775–1775. 6 indexed citations
3.
Hammock, Bruce D., Cindy B. McReynolds, Karen Wagner, et al.. (2021). Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative. Journal of Medicinal Chemistry. 64(4). 1856–1872. 104 indexed citations
4.
Barabutis, Nektarios, Pavel Solopov, Mohammad A. Uddin, et al.. (2020). Protective Mechanism of the Selective Vasopressin V1A Receptor Agonist Selepressin against Endothelial Barrier Dysfunction. Journal of Pharmacology and Experimental Therapeutics. 375(2). 286–295. 9 indexed citations
5.
Hargrove, Diane M., Sudarkodi Alagarsamy, Glenn Croston, et al.. (2020). Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome. Journal of Pharmacology and Experimental Therapeutics. 373(2). 193–203. 41 indexed citations
6.
Wiśniewski, Kazimierz, John E. Kraus, Karthik Srinivasan, et al.. (2019). Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. Journal of Medicinal Chemistry. 62(10). 4991–5005. 7 indexed citations
7.
Laporte, Régent, Halina Wiśniewska, Sudarkodi Alagarsamy, et al.. (2011). Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension. Journal of Pharmacology and Experimental Therapeutics. 337(3). 786–796. 29 indexed citations
8.
Wiśniewski, Kazimierz, Robert Galyean, Sudar Alagarsamy, et al.. (2009). Synthesis and in vitro Pharmacological Profile of Potent and Selective Peptidic V1a Receptor Agonists.. Advances in experimental medicine and biology. 611. 507–508. 8 indexed citations
9.
Samant, Manoj, et al.. (2005). Synthesis, in vivo and in vitro biological activity of novel azaline B analogs. Bioorganic & Medicinal Chemistry Letters. 15(11). 2894–2897. 8 indexed citations
10.
Piu, Fabrice, Roger Olsson, Erika A. Currier, et al.. (2005). Identification of novel subtype selective RAR agonists. Biochemical Pharmacology. 71(1-2). 156–162. 30 indexed citations
11.
Samant, Manoj, et al.. (2004). Novel gonadotropin‐releasing hormone antagonists with substitutions at position 5. Biopolymers. 80(2-3). 386–391. 13 indexed citations
12.
Hacksell, Uli, Norman Nash, Ethan S. Burstein, et al.. (2002). Chemical genomics: massively parallel technologies for rapid lead identification and target validation. Cytotechnology. 38(1-3). 3–10. 4 indexed citations
13.
Croston, Glenn. (2002). Functional cell-based uHTS in chemical genomic drug discovery. Trends in biotechnology. 20(3). 110–115. 37 indexed citations
14.
Hansen, Henrik C., et al.. (2000). Multistep solution-Phase parallel synthesis of spiperone analogues. Bioorganic & Medicinal Chemistry Letters. 10(21). 2435–2439. 6 indexed citations
15.
Mukherjee, Ranjan, Lily Jow, James Bilakovics, et al.. (2000). A Selective Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Modulator Blocks Adipocyte Differentiation but Stimulates Glucose Uptake in 3T3-L1 Adipocytes. Molecular Endocrinology. 14(9). 1425–1433. 116 indexed citations
16.
Mukherjee, Ranjan, Lily Jow, Glenn Croston, & James R. Paterniti. (1997). Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-activated Receptor (PPAR) Isoforms PPARγ2 versus PPARγ1 and Activation with Retinoid X Receptor Agonists and Antagonists. Journal of Biological Chemistry. 272(12). 8071–8076. 372 indexed citations
17.
Lala, Deepak S., Ranjan Mukherjee, Ira G. Schulman, et al.. (1996). Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature. 383(6599). 450–453. 134 indexed citations
18.
Croston, Glenn, Zhaodan Cao, & David V. Goeddel. (1995). NF-κB Activation by Interleukin-1 (IL-1) Requires an IL-1 Receptor-associated Protein Kinase Activity. Journal of Biological Chemistry. 270(28). 16514–16517. 154 indexed citations
19.
Croston, Glenn & James T. Kadonaga. (1993). Role of chromatin structure in the regulation of transcription by RNA polymerase II. Current Opinion in Cell Biology. 5(3). 417–423. 260 indexed citations
20.
Croston, Glenn, et al.. (1991). A general method for purification of H1 histones that are active for repression of basal RNA polymerase II transcription. Protein Expression and Purification. 2(2-3). 162–169. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pengxiang Huang Breakdown of academic impact, for papers by Yi‐Chao Lee Breakdown of academic impact, for papers by Kelly Suino-Powell Breakdown of academic impact, for papers by Yiming Jiang Breakdown of academic impact, for papers by Chakkodabylu S. Ramesha Breakdown of academic impact, for papers by Kentaro Maemura Breakdown of academic impact, for papers by László Hackler Breakdown of academic impact, for papers by Ernesto J. Podestá Breakdown of academic impact, for papers by Boqin Qiang Breakdown of academic impact, for papers by Georges Guellaën
Rankless by CCL
2026